000			02188 a2200625 4500
005			20250516121514.0
264		0	_c20130613
008			201306s 0 0 eng d
022			_a1873-2623
024	7		_a10.1016/j.transproceed.2012.09.054 _2doi
040			_aNLM _beng _cNLM
100	1		_aValor, L
245	0	0	_aEvaluation of lymphoproliferative responses by carboxy fluorescein succinimidyl ester assay in heart recipients with infections. _h[electronic resource]
260			_bTransplantation proceedings _cNov 2012
300			_a2649-52 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAnti-Infective Agents _xadministration & dosage
650	0	4	_aCD4-Positive T-Lymphocytes _xdrug effects
650	0	4	_aCD8-Positive T-Lymphocytes _xdrug effects
650	0	4	_aCase-Control Studies
650	0	4	_aCell Proliferation
650	0	4	_aChi-Square Distribution
650	0	4	_aCommunicable Diseases _xdiagnosis
650	0	4	_aFemale
650	0	4	_aFlow Cytometry
650	0	4	_aFluoresceins
650	0	4	_aFluorescent Dyes
650	0	4	_aHeart Transplantation _xadverse effects
650	0	4	_aHepatitis B Vaccines _xadministration & dosage
650	0	4	_aHumans
650	0	4	_aImmunization Schedule
650	0	4	_aInfluenza Vaccines _xadministration & dosage
650	0	4	_aLymphocyte Activation _xdrug effects
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMitogens
650	0	4	_aPhytohemagglutinins
650	0	4	_aPneumococcal Vaccines _xadministration & dosage
650	0	4	_aPredictive Value of Tests
650	0	4	_aProspective Studies
650	0	4	_aSuccinimides
650	0	4	_aTetanus Toxoid _xadministration & dosage
650	0	4	_aTime Factors
650	0	4	_aTreatment Outcome
700	1		_aSarmiento, E
700	1		_aNavarro, J
700	1		_aGallego, A
700	1		_aFernandez-Yañez, J
700	1		_aFernandez-Cruz, E
700	1		_aCarbone, J
773	0		_tTransplantation proceedings _gvol. 44 _gno. 9 _gp. 2649-52
856	4	0	_uhttps://doi.org/10.1016/j.transproceed.2012.09.054 _zAvailable from publisher's website
999			_c22258811 _d22258811